搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Fusarium solani subsp. pisi Dynein heavy chain, cytoplasmic (DHC1), partial CSB-YP303571FDP
CSB-EP303571FDP
CSB-BP303571FDP
CSB-MP303571FDP
CSB-EP303571FDP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pachysolen tannophilus NAD (P)H-dependent D-xylose reductase CSB-YP303572EQH
CSB-EP303572EQH
CSB-BP303572EQH
CSB-MP303572EQH
CSB-EP303572EQH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Vesicle transport v-SNARE protein vti1 (vti1), partial CSB-YP303574SXV
CSB-EP303574SXV
CSB-BP303574SXV
CSB-MP303574SXV
CSB-EP303574SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Pre-mRNA-splicing factor cwc15 (cwf15) CSB-YP303575SXV
CSB-EP303575SXV
CSB-BP303575SXV
CSB-MP303575SXV
CSB-EP303575SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe 6-phosphogluconate dehydrogenase, decarboxylating (SPBC660.16) CSB-YP303576SXV
CSB-EP303576SXV
CSB-BP303576SXV
CSB-MP303576SXV
CSB-EP303576SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Adenosine kinase (ado1) CSB-YP303577SXV
CSB-EP303577SXV
CSB-BP303577SXV
CSB-MP303577SXV
CSB-EP303577SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Nucleoporin nup186 (nup186), partial CSB-YP303578SXV
CSB-EP303578SXV
CSB-BP303578SXV
CSB-MP303578SXV
CSB-EP303578SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Trehalose-phosphatase (tpp1), partial CSB-YP303579SXV
CSB-EP303579SXV
CSB-BP303579SXV
CSB-MP303579SXV
CSB-EP303579SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Pheromone receptor transcription activator (map1) CSB-YP303580SXV
CSB-EP303580SXV
CSB-BP303580SXV
CSB-MP303580SXV
CSB-EP303580SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces paradoxus Meiotic recombination protein REC114 (REC114) CSB-YP303581SAI
CSB-EP303581SAI
CSB-BP303581SAI
CSB-MP303581SAI
CSB-EP303581SAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica pH-response transcription factor pacC/RIM101 (RIM101), partial CSB-YP303582YAP
CSB-EP303582YAP
CSB-BP303582YAP
CSB-MP303582YAP
CSB-EP303582YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Transcriptional activator hap5 (hap5) CSB-YP303583SXV
CSB-EP303583SXV
CSB-BP303583SXV
CSB-MP303583SXV
CSB-EP303583SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe 40S ribosomal protein S19-B (rps19b) CSB-YP303584SXV
CSB-EP303584SXV
CSB-BP303584SXV
CSB-MP303584SXV
CSB-EP303584SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe ATP-dependent helicase rhp16 (rhp16), partial CSB-YP303585SXV
CSB-EP303585SXV
CSB-BP303585SXV
CSB-MP303585SXV
CSB-EP303585SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe DNA damage tolerance protein rad31 (rad31) CSB-YP303586SXV
CSB-EP303586SXV
CSB-BP303586SXV
CSB-MP303586SXV
CSB-EP303586SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trametes versicolor Pyranose 2-oxidase (P2OX), partial CSB-YP303587TPK
CSB-EP303587TPK
CSB-BP303587TPK
CSB-MP303587TPK
CSB-EP303587TPK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Cleavage and polyadenylation specificity factor subunit 3 (CPSF3), partial CSB-YP303589BO
CSB-EP303589BO
CSB-BP303589BO
CSB-MP303589BO
CSB-EP303589BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Low affinity immunoglobulin gamma Fc region receptor III (FCGR3), partial CSB-YP303590BO
CSB-EP303590BO
CSB-BP303590BO
CSB-MP303590BO
CSB-EP303590BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig Metallothionein-2B (MT2B) CSB-YP303591PI
CSB-EP303591PI
CSB-BP303591PI
CSB-MP303591PI
CSB-EP303591PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage Mu Tail tube protein (M) CSB-YP303592EDA
CSB-EP303592EDA
CSB-BP303592EDA
CSB-MP303592EDA
CSB-EP303592EDA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>